128 related articles for article (PubMed ID: 10710095)
1. Complete regression of hepatocellular carcinoma under tamoxifen.
Castéra L; Boige V; Rocher L; Duclos-Vallée JC; Fabre M; Buffet C
Am J Gastroenterol; 2000 Mar; 95(3):827-9. PubMed ID: 10710095
[No Abstract] [Full Text] [Related]
2. [Tamoxifen and hepatocarcinoma].
Mondragón Sánchez R
Rev Gastroenterol Mex; 1998; 63(3):169. PubMed ID: 10068765
[No Abstract] [Full Text] [Related]
3. Complete, long-standing regression of hepatocellular carcinoma after somatostatin analogue treatment.
Rahmi G; Malka D; Tomasic G; Dromain C; Ducreux M; Boige V
J Clin Oncol; 2007 Jun; 25(16):e15-6. PubMed ID: 17538153
[No Abstract] [Full Text] [Related]
4. Regression of a hepatocellular carcinoma following treatment with octreotide and tamoxifen in a patient with advanced alcoholic cirrhosis.
Senturk H; Canbakan B; Cumali R
J Gastroenterol Hepatol; 2004 Jun; 19(6):719-20. PubMed ID: 15151636
[No Abstract] [Full Text] [Related]
5. [Treatment of hepatocellular carcinoma with tamoxifen].
Raoul JL
Gastroenterol Clin Biol; 1996 Mar; 20(2):221-2. PubMed ID: 8761695
[No Abstract] [Full Text] [Related]
6. [Tamoxifen and hepatocellular carcinoma: verdict after enthusiasm...].
Barbare JC
Gastroenterol Clin Biol; 1996; 20(6-7):609-10. PubMed ID: 8881581
[No Abstract] [Full Text] [Related]
7. Tamoxifen in hepatocellular carcinoma.
Chow P; Kiat TC; Choo TB; Machin D
Lancet; 1998 Sep; 352(9130):819-20. PubMed ID: 9737316
[No Abstract] [Full Text] [Related]
8. Tamoxifen does not improve overall survival in people with advanced-stage hepatocellular carcinoma.
Chow PK
Cancer Treat Rev; 2005 Oct; 31(6):491-5. PubMed ID: 16214294
[No Abstract] [Full Text] [Related]
9. Tamoxifen treatment in hepatocellular carcinoma.
Farinati F
Gastroenterology; 1996 Jul; 111(1):272-4. PubMed ID: 8698220
[No Abstract] [Full Text] [Related]
10. Variant liver estrogen and response to tamoxifen.
Villa E; Camellini L; Dugani A; Buttafoco P; Grottola A; Manenti F
Gastroenterology; 1996 Jul; 111(1):271-2. PubMed ID: 8698219
[No Abstract] [Full Text] [Related]
11. Response of negative estrogen-receptor hepatocarcinoma to tamoxifen, and survival of non-resectable patients.
García-Leiva J; Gamboa-Domínguez A; Ceron-Lizarraga T; Morales-Espinosa D; Meza-Junco J; Arrieta O
Ann Hepatol; 2006; 5(4):263-7. PubMed ID: 17151578
[TBL] [Abstract][Full Text] [Related]
12. Use of tamoxifen in hepatocellular carcinoma: a review and paradigm shift.
Tan CK; Chow PK; Findlay M; Wong C; Machin D
J Gastroenterol Hepatol; 2000 Jul; 15(7):725-9. PubMed ID: 10937676
[TBL] [Abstract][Full Text] [Related]
13. [Complete remission of hepatocarcinoma metastasis during palliative treatment with tamoxifen].
Morra A; Sponza M; Stanta G; Urban F; Frezza M
Radiol Med; 1998 Sep; 96(3):263-5. PubMed ID: 9850724
[No Abstract] [Full Text] [Related]
14. Re: Liu et al.--Estrogen receptor status in inoperable hepatocellular carcinoma.
Chow PK; Hung H; Soo KC
Am J Gastroenterol; 2001 Apr; 96(4):1297-8. PubMed ID: 11316190
[No Abstract] [Full Text] [Related]
15. Systemic treatment of hepatocellular carcinoma.
Treiber G
Dig Dis; 2001; 19(4):311-23. PubMed ID: 11935091
[TBL] [Abstract][Full Text] [Related]
16. [Regression of hepatocellular carcinoma under Tamoxifen: report of one case and review of the literature].
Macaigne G; Auriault ML; Boivin JF; Cheaib S; Chayette C; Deplus R
Gastroenterol Clin Biol; 2002 Dec; 26(12):1165-7. PubMed ID: 12520204
[TBL] [Abstract][Full Text] [Related]
17. [Does anti-estrogen therapy after estrogen receptor analysis have value in palliative therapy of hepatocellular carcinoma?].
Kreysel C; Porschen R
Z Gastroenterol; 1998 Jul; 36(7):605-7. PubMed ID: 9738309
[No Abstract] [Full Text] [Related]
18. Tamoxifen for the treatment of malignancies other than breast and endometrial carcinoma.
Gelmann EP
Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-65-S1-70. PubMed ID: 9045318
[TBL] [Abstract][Full Text] [Related]
19. Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized study.
Liu CL; Fan ST; Ng IO; Lo CM; Poon RT; Wong J
Am J Gastroenterol; 2000 Jan; 95(1):218-22. PubMed ID: 10638587
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma.
Barbare JC; Bouché O; Bonnetain F; Raoul JL; Rougier P; Abergel A; Boige V; Denis B; Blanchi A; Pariente A; Milan C; Bedenne L
J Clin Oncol; 2005 Jul; 23(19):4338-46. PubMed ID: 15994145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
